HNF1A-AS1 promotes oral squamous cell carcinoma progression via regulating miR-138/CDK6 pathway

被引:0
|
作者
Mei, Bingxin [1 ]
Zeng, Zhimei [1 ]
Xia, Qinmin [1 ]
Liu, Ming [1 ]
Lei, Li [1 ]
机构
[1] Gannan Med Univ, Dept Stomatol, Affiliated Hosp 1, 128 Jinling Rd, Ganzhou 341000, Jiangxi, Peoples R China
关键词
HNF1A-AS1; miR-138; CDK6; Progression; OSCC; UP-REGULATION; RESISTANCE;
D O I
10.1007/s10266-025-01057-w
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The action and the latent mechanism of HNF1A-AS1 in oral squamous cell carcinoma (OSCC) development were probed. Levels of HNF1A-AS1, microRNA-138 (miR-138) and Cyclin-dependent kinase 6 (CDK6) were examined. In vitro assays were conducted using SCC-4 and SCC15 cells derived from a human SCC of the tongue of a 55-year-old male. In vivo assay was performed by establishing OSCC mouse models. An elevated HNF1A-AS1 was detected in OSCC, and down-expressed HNF1A-AS1 inhibited migration and invasion, and promoted apoptosis in OSCC cells in vitro. HNF1A-AS1 targeted miR-138 to positively regulate the expression of CDK6, a target of miR-138. Knockdown of miR-138 attenuated the action of HNF1A-AS1 silencing on OSCC cell malignant phenotypes. Besides that, overexpression of CDK6 weakened miR-138-mediated anti-cancer functions. Moreover, HNF1A-AS1 knockdown restrained OSCC growth in nude mice. HNF1A-AS1 promoted OSCC tumorigenesis via miR-138/CDK6 pathway, indicating the potential molecular contribution of HNF1A-AS1 on OSCC pathogenesis.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR-138 and releasing EZH2 in oral squamous cell carcinoma
    Hong, Yonglong
    He, Haitao
    Sui, Wen
    Zhang, Jingge
    Zhang, Shenfu
    Yang, Dajiang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) : 901 - 912
  • [22] Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis
    Li, Minghe
    Ning, Jun
    Li, Zhihong
    Fei, Qianyi
    Zhao, Cong
    Ge, Yue
    Wang, Lei
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [23] Dysregulation of AKT1, a miR-138 target gene, is involved in the migration and invasion of tongue squamous cell carcinoma
    Ji, Muyuan
    Wang, Wei
    Yan, Wangxiang
    Chen, Dan
    Ding, Xueqiang
    Wang, Anxun
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2017, 46 (09) : 731 - 737
  • [24] LncRNA PVT1 promotes malignant progression by regulating the miR-7-5p/CDKL1 axis in oral squamous cell carcinoma
    Li, Jun
    Ding, Shuxin
    Li, Min
    Zou, Bo
    Chu, Miaomiao
    Gu, Guohao
    Chen, Cheng
    Liu, Yu-jiao
    Zheng, Ke
    Meng, Zhen
    MOLECULAR AND CELLULAR PROBES, 2024, 78
  • [25] lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis
    Guo, Haiyan
    Lin, Shufang
    Gan, Zhenyong
    Xie, Jinglian
    Zhou, Jiaming
    Hu, Ming
    ONCOLOGY LETTERS, 2021, 22 (06)
  • [26] LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis
    Liu, Ying
    Li, Lei
    Shang, Peng
    Song, Xiang
    ANTI-CANCER DRUGS, 2020, 31 (10) : 1065 - 1073
  • [27] MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma
    Ma, Fei
    Zhang, Mingdi
    Gong, Wei
    Weng, Mingzhe
    Quan, Zhiwei
    PLOS ONE, 2015, 10 (05):
  • [28] MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6
    Wei, Lei
    Wang, Bo
    Hu, Liwen
    Xu, Yang
    Li, Zhongdong
    Shen, Yi
    Huang, Hairong
    AGING-US, 2020, 12 (21): : 21091 - 21113
  • [29] METTL14 Promotes Oral Squamous Cell Carcinoma Progression by Regulating the mRNA and m6A Levels of CALD1
    Chen, Ruixue
    Zhang, Suxin
    Li, Hexiang
    Yang, Mengyuan
    Lu, Yiwen
    Zhang, Xudong
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2023, 42 (03) : 71 - 81
  • [30] LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis
    Chu, Jie
    Li, Hongle
    Xing, Yurong
    Jia, Jinlin
    Sheng, Jinxiu
    Yang, Lijun
    Sun, Kaiyan
    Qu, Yunhui
    Zhang, Yan
    Yin, Huiqing
    Wa, Junhu
    He, Fucheng
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 116